Literature DB >> 11000618

Disseminated Mycobacterium bovis after intravesicular bacillus calmette-Gu rin treatments for bladder cancer.

M Elkabani1, J N Greene, A L Vincent, S VanHook, R L Sandin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11000618     DOI： 10.1177/107327480000700512

Source DB:  PubMed          Journal:  Cancer Control        ISSN： 1073-2748            Impact factor:   3.302


× No keyword cloud information.
  17 in total

1.  Severe disseminated tuberculosis after intravesical instillation of Bacillus Calmette-Guérin.

Authors:  M Toscano Rico; J Machado; O Cardoso; C Salvado; P Rodrigues; R Proença
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

2.  Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer.

Authors:  Vincent Fradet; Christiane Gaudreau; Paul Perrotte; Jean Côté; Jean-Marie Paquin
Journal:  Can Urol Assoc J       Date:  2007-09       Impact factor: 1.862

3.  Concurrent granulomatous hepatitis, pneumonitis and sepsis as a complication of intravesical BCG immunotherapy.

Authors:  Vasiliki Delimpoura; Konstantinos Samitas; Ioannis Vamvakaris; Eleftherios Zervas; Mina Gaga
Journal:  BMJ Case Rep       Date:  2013-10-10

4.  Subclinical miliary Mycobacterium bovis following BCG immunotherapy for transitional cell carcinoma of the bladder.

Authors:  Chang-Ho Ryan Choi; Sang Oh Lee; Geoff Smith
Journal:  BMJ Case Rep       Date:  2014-05-08

5.  Acute renal failure due to interstitial nephritis after intravesical instillation of BCG.

Authors:  Maria Jose Manzanera Escribano; Enrique Morales Ruiz; Mónica Odriozola Grijalba; Eduardo Gutierrez Martínez; Alfredo Rodriguez Antolín; Manuel Praga Terente
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

6.  Disseminated infection due to Mycobacterium bovis after intravesical BCG instillation.

Authors:  Sara Marquez-Batalla; Esther Fraile-Villarejo; Moncef Belhassen-García; Nieves Gutierrez-Zubiaurre; Miguel Cordero-Sánchez
Journal:  World J Clin Cases       Date:  2014-07-16       Impact factor: 1.337

7.  Investigation of granulomatous prostatitis incidence following intravesical BCG therapy.

Authors:  Mehmet Balasar; Metin Doğan; Abdulkadir Kandemir; Hakan Hakki Taskapu; Faruk Cicekci; Hatice Toy; Recai Gurbuz
Journal:  Int J Clin Exp Med       Date:  2014-06-15

8.  Systemic granulomatous reaction secondary to treatment of bladder cancer with bacillus calmette-guerin.

Authors:  Caterina Giovanna Valentini; Valentina Bozzoli; Anna Rita Larici; Luigi Maria Larocca; Giovanni Delogu; Giuseppe Leone; Livio Pagano
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-06-18       Impact factor: 2.576

Review 9.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

10.  Effectiveness of Steroid Pulse Therapy for Systemic Side Effects after Bacillus Calmette-Guérin Intravesical Instillation Therapy: A Series of Five Cases.

Authors:  Tatsuya Umemoto; Jun Naruse; Yukio Usui; Hidenori Zakoji; Hideshi Miyakita; Akira Miyajima
Journal:  Case Rep Urol       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.